Quick Answer
International Stem Cell CORP reported Operating Income Loss of -$267.0 thousand for the year ending 2025.
- International Stem Cell CORP showed a decrease of -292.6% in Operating Income Loss from 2024 to 2025.
- This data is from International Stem Cell CORP's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: -$1.71 million | Q2 2013: -$2.19 million | Q3 2013: -$1.70 million | Q1 2014: -$2.07 million | Q2 2014: -$2.24 million | Q3 2014: -$2.03 million | Q1 2015: -$1.97 million | Q2 2015: -$937.0 thousand | Q3 2015: -$622.0 thousand | Q1 2016: -$1.17 million | Q2 2016: -$1.25 million | Q3 2016: -$1.26 million | Q1 2017: -$1.05 million | Q2 2017: -$1.00 million | Q3 2017: -$970.0 thousand | Q1 2018: -$1.19 million | Q2 2018: -$367.0 thousand | Q3 2018: -$663.0 thousand | Q1 2019: -$1.49 million | Q2 2019: -$941.0 thousand | Q3 2019: -$813.0 thousand | Q1 2020: -$455.0 thousand | Q2 2020: -$832.0 thousand | Q3 2020: -$798.0 thousand | Q1 2021: -$567.0 thousand | Q2 2021: -$406.0 thousand | Q3 2021: -$623.0 thousand | Q1 2022: $25.0 thousand | Q2 2022: $31.0 thousand | Q3 2022: -$300.0 thousand | Q1 2023: $2.0 thousand | Q2 2023: -$144.0 thousand | Q3 2023: -$97.0 thousand | Q1 2024: -$178.0 thousand | Q2 2024: $149.0 thousand | Q3 2024: -$90.0 thousand | Q1 2025: -$215.0 thousand | Q2 2025: $167.0 thousand | Q3 2025: $94.0 thousand.
- Over the full 16 years of available data (2010 to 2025), International Stem Cell CORP's Operating Income Loss has grown by 97.4%.
- Historical annual values: Fiscal year 2025: -$267.0 thousand | Fiscal year 2024: -$68.0 thousand | Fiscal year 2023: -$663.0 thousand | Fiscal year 2022: -$183.0 thousand | Fiscal year 2021: -$1.92 million | Fiscal year 2020: -$2.82 million | Fiscal year 2019: -$5.73 million | Fiscal year 2018: -$3.47 million | Fiscal year 2017: -$4.94 million | Fiscal year 2016: -$4.85 million | Fiscal year 2015: -$4.56 million | Fiscal year 2014: -$8.68 million | Fiscal year 2013: -$7.55 million | Fiscal year 2012: -$9.82 million | Fiscal year 2011: -$11.36 million | Fiscal year 2010: -$10.46 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: